Sutro Biopharma, Inc.STRONASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank89
3Y CAGR+13.5%
5Y CAGR+21.1%
Year-over-Year Change
Research and development spending
3Y CAGR
+13.5%/yr
vs +26.1%/yr prior
5Y CAGR
+21.1%/yr
Recent deceleration
Acceleration
-12.5pp
Decelerating
Percentile
P89
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $200.81M | -20.3% |
| 2024 | $252.04M | +39.7% |
| 2023 | $180.43M | +31.5% |
| 2022 | $137.17M | +31.4% |
| 2021 | $104.40M | +35.7% |
| 2020 | $76.96M | +17.3% |
| 2019 | $65.61M | +20.9% |
| 2018 | $54.26M | -0.7% |
| 2017 | $54.64M | +25.5% |
| 2016 | $43.55M | - |